Molworks Competitors

Chemaxon is a leading cheminformatics company, setting the industry standard for quality and accuracy. Over 1 million scientists, academics, and researchers use our tools to streamline their workflows and power their scientific breakthroughs. Chemaxon joined Certara in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines.

Advanced Chemistry Development, Inc., (ACD/Labs) develops and commercialzes informatics solutions for chemical, biochemical, and pharmaceutical R&D. Our expertise lies in vendor-agnostic spectroscopic and chromatographic data processing and prediction, physicochemical and ADME-Tox property prediction, analytical knowledge management, interactive reporting, and integrating analytical data with chemical structures to help protect and leverage valuable research knowledge. ACD/Labs' solutions help scientists and their organizations to share and reuse accumulated knowledge more efficiently, to get products to market faster—the vital business necessity of our times. Serving customers since 1994, ACD/Labs has developed a number of industry leading software tools, including ACD/Structure Elucidator, an Automated Structure Verification solution, pKa property predictor, renowned ACD/Name chemical nomenclature software, ACD/AutoChrom, a MetID solution, a Biotransformation knowledge management package, not to mention our consistently popular NMR Processing and prediction software. ADMET predictive software and Structure Design and Lead Optimization tools have been added and augmented since the late 2000's. In recent years, the company delivered new informatics platforms-Percepta and Spectrus (www.acdlabs.com/percepta and www.acdlabs.com/spectrus)-to stay abreast of our customers' latest requirements.

Cresset® is revolutionizing molecule design and cross-team communication, combining cutting-edge science with AI/ML to enable our customers to discover new compounds faster and more efficiently. Chemists in the world’s leading research organizations use Cresset solutions to discover, design, optimize, synthesize and track the best small molecules. By integrating their in silico CADD and DMTA discovery solutions with Cresset’s first-class discovery research resources, researchers will have access to patented CADD Software, collaborative Torx® DMTA platform and expert Discovery CRO scientists. In helping organizations reach better design and synthesis decisions faster and more efficiently, we enable them to win the race to success in industries including: pharmaceuticals, agrochemicals, flavors and fragrances.